Cancer screening resident survival guide

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]

Overview

This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.

Common Cancers

Breast Cancer

Cervical Cancer

Recommendations for Cervical cancer screening:[3]
Population Screening recommendations
Immunocompromised
  • onset of sexual intercourse
Age less than 21
  • screening not recommended
Age 21-29
Age 30-65
Age 65 or greater than 65

Discontinue cervical cancer screening

To view the detailed information on cervical cancer screening click here.

Colorectal Cancer

Endometrial Cancer

Esophageal Cancer

Lung Cancer

  • Lung cancer screening starts among asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit smoking within the past 15 years.[5]
  • According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, Lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death in both males and females (18.4% of the total cancer deaths).[2]
Recommendations for lung cancer screening:[5]
Recommended test
Recommended Interval
  • Annual screening (every year)
Age for screening
  • 55-80
Eligibility for screening based on smoking history
  • Patient has 30 or greater than 30-pack-year smoking history and patient is a current smoker or quite smoking within the last 15 years.
Discontinuation of screening
  • Age greater than 80 or
  • Patient successfully quit smoking for 15 years and beyond or
  • Patient has other medical problems that significantly limit life expectancy or ability/willingness to undergo lung cancer surgery.

Ovarian cancer

  • There are no recommendations for screening ovarian cancer in asymptomatic women although the better outcome is associated with early diagnosis.[6]
  • To view the detailed information on ovarian cancer screening click here.

Prostate Cancer

  • According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, Prostate cancer is the second cause of cancer death in males (7.1% of the total cancer deaths).[2]

References

  1. "Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce".
  2. 2.0 2.1 2.2 2.3 2.4 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". CA Cancer J Clin. 68 (6): 394–424. doi:10.3322/caac.21492. PMID 30207593.
  3. 3.0 3.1 "Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce".
  4. US Preventive Services Task Force. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW; et al. (2016). "Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 315 (23): 2564–2575. doi:10.1001/jama.2016.5989. PMID 27304597.
  5. 5.0 5.1 "Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce". Retrieved 8/3/2020. Check date values in: |accessdate= (help)
  6. "Recommendation: Ovarian Cancer: Screening | United States Preventive Services Taskforce".